Treatment of tobacco use disorders in smokers with serious mental illness: toward clinical best practices
- PMID: 25747922
- PMCID: PMC4460830
- DOI: 10.1097/HRP.0000000000000063
Treatment of tobacco use disorders in smokers with serious mental illness: toward clinical best practices
Abstract
Addiction to tobacco-derived nicotine remains highly prevalent in the United States, with 18% using daily, and 53% of those with serious mental illness using daily. While smokers with serious mental illness have been excluded from most large nicotine-dependence treatment studies, a growing evidence base is available to guide clinicians in assisting their patients with psychiatric illness to quit smoking. The aim of this review is to present the evidence on safety and efficacy of smoking cessation interventions for those with serious mental illness. Smokers with schizophrenia spectrum disorders should receive varenicline or bupropion with or without nicotine replacement therapy in combination with behavioral treatment. Although more research is needed, preliminary evidence suggests that varenicline in combination with behavioral support is efficacious and well tolerated for smoking cessation for those with bipolar disorder and major depressive disorder. Controlled trials have found no evidence that in patients with serious mental illness, the use of pharmacotherapeutic cessation aids worsens psychiatric symptoms or increases the rate of psychiatric adverse events. Converging evidence indicates that a majority of smokers with serious mental illness want to quit smoking and that available pharmacotherapeutic cessation aids combined with behavioral support are both effective for, and well tolerated by, these smokers.
Similar articles
-
Smoking cessation medicines and e-cigarettes: a systematic review, network meta-analysis and cost-effectiveness analysis.Health Technol Assess. 2021 Oct;25(59):1-224. doi: 10.3310/hta25590. Health Technol Assess. 2021. PMID: 34668482
-
Achieving Smoking Cessation in Individuals with Schizophrenia: Special Considerations.CNS Drugs. 2017 Jun;31(6):471-481. doi: 10.1007/s40263-017-0438-8. CNS Drugs. 2017. PMID: 28550660 Free PMC article. Review.
-
Efficacy and tolerability of pharmacotherapy for smoking cessation in adults with serious mental illness: a systematic review and network meta-analysis.Addiction. 2016 Apr;111(4):599-612. doi: 10.1111/add.13236. Epub 2016 Jan 19. Addiction. 2016. PMID: 26594837 Free PMC article. Review.
-
Effective Cessation Strategies for Smokers with Schizophrenia.Int Rev Neurobiol. 2015;124:133-47. doi: 10.1016/bs.irn.2015.08.001. Epub 2015 Sep 14. Int Rev Neurobiol. 2015. PMID: 26472528 Review.
-
Maintenance treatment with varenicline for smoking cessation in patients with schizophrenia and bipolar disorder: a randomized clinical trial.JAMA. 2014 Jan 8;311(2):145-54. doi: 10.1001/jama.2013.285113. JAMA. 2014. PMID: 24399553 Free PMC article. Clinical Trial.
Cited by
-
The Whole Package: A Multi-Component Smoking Cessation Intervention for Adults With Serious Mental Illness: A Qualitative Study.Tob Use Insights. 2024 May 21;17:1179173X241253229. doi: 10.1177/1179173X241253229. eCollection 2024. Tob Use Insights. 2024. PMID: 38779493 Free PMC article.
-
New medications development for smoking cessation.Addict Neurosci. 2023 Sep;7:100103. doi: 10.1016/j.addicn.2023.100103. Epub 2023 May 18. Addict Neurosci. 2023. PMID: 37519910 Free PMC article.
-
Promoting Evidence-Based Tobacco Cessation Treatment in Community Mental Health Clinics: Protocol for a Prepost Intervention Study.JMIR Res Protoc. 2023 May 12;12:e44787. doi: 10.2196/44787. JMIR Res Protoc. 2023. PMID: 37171851 Free PMC article.
-
A randomized clinical trial testing two implementation strategies to promote the treatment of tobacco dependence in community mental healthcare.Drug Alcohol Depend. 2023 Jun 1;247:109873. doi: 10.1016/j.drugalcdep.2023.109873. Epub 2023 Apr 12. Drug Alcohol Depend. 2023. PMID: 37084508 Free PMC article. Clinical Trial.
-
Prevalence of physical health conditions and health risk behaviours in people with severe mental illness in South Asia: multi-country cross-sectional survey.BJPsych Open. 2023 Feb 23;9(2):e43. doi: 10.1192/bjo.2023.12. BJPsych Open. 2023. PMID: 36815449 Free PMC article.
References
-
- USDHHS. The Health Consequences of Smoking: 50 Years of Progress: A Report of the Surgeon General. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Healthy. 2014 - PubMed
-
- Dickerson F, Stallings CR, Origoni AE, et al. Cigarette smoking among persons with schizophrenia or bipolar disorder in routine clinical settings, 1999–2011. Psychiatr Serv. 2013 Jan;64(1):44–50. - PubMed